Old Web
English
Sign In
Acemap
>
authorDetail
>
Jean‐Claude Marshall
Jean‐Claude Marshall
Pfizer
Medicine
Pharmacokinetics
Anesthesia
Diabetes mellitus
CYP3A4
5
Papers
68
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Use of Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Axitinib Exposure: A Fresh Approach to Precision Dosing in Oncology
2019
The Journal of Clinical Pharmacology
Michael J. Sorich
Fayzah Mutlib
Madelé van Dyk
Ashley M. Hopkins
Thomas M. Polasek
Jean‐Claude Marshall
A. David Rodrigues
Andrew Rowland
Show All
Source
Cite
Save
Citations (9)
Plasma extracellular nanovesicle (exosome)‐derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure
2019
British Journal of Clinical Pharmacology
Andrew Rowland
Warit Ruanglertboon
Madelé van Dyk
Dhilushi Wijayakumara
Linda S. Wood
Robyn Meech
Peter I. Mackenzie
A. David Rodrigues
Jean‐Claude Marshall
Michael J. Sorich
Show All
Source
Cite
Save
Citations (40)
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects
2019
The Journal of Clinical Pharmacology
Manoli Vourvahis
Lynn McFadyen
Sunil Nepal
Srinivas Rao Valluri
Annie Fang
Gwendolyn D. Fate
Linda S. Wood
Jean‐Claude Marshall
Phylinda L. S. Chan
Angus Nedderman
Julian J Haynes
Mark E. Savage
Andrew Clark
Kimberly Y. Smith
Jayvant Heera
Show All
Source
Cite
Save
Citations (1)
Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries
2018
European Journal of Clinical Pharmacology
Madelé van Dyk
Jean‐Claude Marshall
Michael J. Sorich
Linda S. Wood
Andrew Rowland
Show All
Source
Cite
Save
Citations (18)
Exploring Relationships of Exposure, Pharmacodynamic Changes and Gene Expression to Clinical Outcome in Adults with Acute Lymphoblastic Leukemia Receiving Inotuzumab Ozogamicin
2015
Blood
Luke Fostvedt
A. Douglas Laird
Jean‐Claude Marshall
Sherry Li
Joseph Boni
Show All
Source
Cite
Save
Citations (0)
1